Recent research has shown that NRF2 activation regulates autophagy, unfolded protein response (UPR), micropinocytosis, and metabolic reprogramming, all contributing to cancer cell survival and treatment resistance [38]. This evidence concerns the gene NFE2L2 and cancer.